Bioventus Inc. Class A Common Stock (BVS) Technical Analysis
$14.26▲2.66%
Market is closed - opens 7 PM, 17 Aug 2026
Insights
- Bioventus Inc. Class A is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Bioventus Inc. Class A stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Bioventus Inc. Class A stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Bioventus Inc. Class A stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 64.77 | Sell |
Stochastic | 52.92, 52.23 | Neutral |
Ultimate Oscillator | 66.33 | Neutral |
Stochastic Relative Strength Index | 11.39, 16.5 | Neutral |
Moving Average Convergence Divergence | 0.79, 0.82 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 14.01 | Buy |
20 | 13.18 | Buy |
50 | 11.33 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 13.84 | Buy |
20 | 13.27 | Buy |
50 | 11.97 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 14.05 | Neutral |
20 | 13.4 | Buy |
50 | 11.64 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 14.28 | Sell |
20 | 14.36 | Buy |
50 | 13.48 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 14.17 | Sell |
20 | 14.45 | Buy |
50 | 14.27 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 14.34 |
Resistance L2 | 14.18 |
Resistance L1 | 14.04 |
Pivot Point | 13.88 |
Support L1 | 13.74 |
Support L2 | 13.58 |
Support L3 | 13.44 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.